|
BPGM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72473146875518E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.42830216940138E-11 |
| Normal-vs-Stage2 |
2.141800E-02 |
| Normal-vs-Stage3 |
4.63449999488219E-08 |
| Normal-vs-Stage4 |
2.769300E-04 |
| Stage1-vs-Stage2 |
1.173250E-01 |
| Stage1-vs-Stage3 |
2.585000E-01 |
| Stage1-vs-Stage4 |
3.813000E-01 |
| Stage2-vs-Stage3 |
2.364400E-02 |
| Stage2-vs-Stage4 |
6.632000E-02 |
| Stage3-vs-Stage4 |
9.138800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.45754544387E-13 |
| Normal-vs-AfricanAmerican |
3.312400E-02 |
| Normal-vs-Asian |
1.795880E-04 |
| Caucasian-vs-AfricanAmerican |
9.136800E-01 |
| Caucasian-vs-Asian |
5.900000E-01 |
| AfricanAmerican-vs-Asian |
7.311600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.64250000000066E-05 |
| Normal-vs-Female |
1.66300306858602E-12 |
| Male-vs-Female |
6.591700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.9478000302704E-09 |
| Normal-vs-Age(41-60Yrs) |
2.45800046982936E-10 |
| Normal-vs-Age(61-80Yrs) |
2.027000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.316400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.464800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.720600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.739400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.508000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.918970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.022600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.803540E-04 |
| Classical-VS-Follicular |
3.91010002154246E-09 |
| Classical-VS-Other |
2.019600E-01 |
| Classical-VS-Normal |
1.63946634046397E-12 |
| Tall-VS-Follicular |
1.73950000004197E-06 |
| Tall-VS-Other |
1.428040E-02 |
| Tall-VS-Normal |
2.40280000007864E-07 |
| Follicular-VS-Other |
8.481000E-01 |
| Follicular-VS-Normal |
1.124610E-01 |
| Other-VS-Normal |
5.650800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09370000000997E-06 |
| Normal-vs-N1 |
4.43650000000462E-05 |
| N0-vs-N1 |
6.584000E-02 |
|
|
